Intensity Therapeutics, Inc. (INTS)

Intensity Therapeutics Statistics

Total Valuation

INTS has a market cap or net worth of $13.09 million. The enterprise value is $11.00 million.

Market Cap	13.09M
Enterprise Value	11.00M

Important Dates

The next estimated earnings date is Friday, November 7, 2025, after market close.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

INTS has 49.06 million shares outstanding. The number of shares has increased by 13.30% in one year.

Current Share Class	49.06M
Shares Outstanding	49.06M
Shares Change (YoY)	+13.30%
Shares Change (QoQ)	+24.35%
Owned by Insiders (%)	7.18%
Owned by Institutions (%)	6.63%
Float	42.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.20
P/TBV Ratio	5.99
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.40, with a Debt / Equity ratio of 0.06.

Current Ratio	1.40
Quick Ratio	1.02
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -334.12% and return on invested capital (ROIC) is -206.15%.

Return on Equity (ROE)	-334.12%
Return on Assets (ROA)	-122.67%
Return on Invested Capital (ROIC)	-206.15%
Return on Capital Employed (ROCE)	-564.81%
Revenue Per Employee	n/a
Profits Per Employee	-$1.80M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.59% in the last 52 weeks. The beta is 3.67, so INTS's price volatility has been higher than the market average.

Beta (5Y)	3.67
52-Week Price Change	-91.59%
50-Day Moving Average	0.27
200-Day Moving Average	0.97
Relative Strength Index (RSI)	51.20
Average Volume (20 Days)	5,816,848

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.87M
Pretax Income	-12.58M
Net Income	-12.58M
EBITDA	n/a
EBIT	-12.87M
Earnings Per Share (EPS)	-$0.81

Balance Sheet

The company has $2.22 million in cash and $125,000 in debt, giving a net cash position of $2.09 million or $0.04 per share.

Cash & Cash Equivalents	2.22M
Total Debt	125,000
Net Cash	2.09M
Net Cash Per Share	$0.04
Equity (Book Value)	2.18M
Book Value Per Share	0.08
Working Capital	874,000

Cash Flow

Operating Cash Flow	-11.09M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

INTS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.30%
Shareholder Yield	-13.30%
Earnings Yield	-96.07%
FCF Yield	n/a

Analyst Forecast

The average price target for INTS is $4.50, which is 1,586.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.50
Price Target Difference	1,586.03%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1